Lung cancer diagnostic co Body Vision Medical raises $8.5m

Cancerous cells Photo: Shutterstock

The Israeli company specializes in lung cancer diagnostics through augmented real-time intra-body navigation and imaging.

Israeli medical device company Body Vision Medical announced today that it had raised $8.5 million in funding. Based in Ramat Hasharon, the company specializes in lung cancer diagnostics through augmented real-time intra-body navigation and imaging. The proceeds will be used to accelerate the commercialization efforts of its FDA approved LungVision system in the US and to extend its product line.

Body Vision Medical founder and CEO Dorian Averbuch said, "The LungVision system introduces a novel real-time imaging tool to the bronchoscopy suite. Today, in order to diagnose small peripheral lesions, the pulmonologist has to use several different imaging modalities such as computerized tomography (CT), ultrasound (US) and fluoroscopy. Each of these modalities has advantages and disadvantages; however, even a combination of all of the above was unable to improve significantly a poor diagnostic yield of small peripheral lung lesions."

He added, "For the first time, our fusion imaging platform enables the pulmonologist to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The LungVision™ system, together with our unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics." Body Vision Medical chairman Zohar Gilon, who led the financing round, said, "It's been an immaculate journey to observe and support the company from the concept phase to where it is today, having two systems cleared by the FDA and solid clinical data from 400 patients in leading centers in the US."

He continued, "From the very start we believed that the company was tackling substantial unmet needs utilizing a very novel and very promising approach. Dorian and his world-class team will save a great number of lives, and almost as important, decrease and shorten many families' pain and suffering. I was privileged to lead the financing of Body Vision from inception, and I was honored by about 20 of Israel's leading tech entrepreneurs and investors who joined me."

Published by Globes [online], Israel business news - - on September 4, 2018

© Copyright of Globes Publisher Itonut (1983) Ltd. 2018

Cancerous cells Photo: Shutterstock
Cancerous cells Photo: Shutterstock
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018